Concepedia

Hiroshi Yoshino

HY

Statistics

Publications

34

Citations

2.1K

H-Index

22

Active since

1969

Affiliations

Yamasa Corporation (Japan)(Current)

Nagasaki University

National Institute Of Hygiene And Epidemiology

Khanh Hoa General Hospital

Hiroshi Yoshino is an author at Yamasa Corporation (Japan) specializing in pharmacology, enzymology, and biochemistry.

Publications per year

1969–2017

34

Publications

34

Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle

Takashi Owa, Hiroshi Yoshino, Tatsuo Okauchi et al. · Journal of Medicinal Chemistry · 1999 · 325 citations

Medicine, Oncology, Pharmacology +13

Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor

Takahiro Ueda, Kohichiro Tsuji, Hiroshi Yoshino et al. · Journal of Clinical Investigation · 2000 · 282 citations · Full text

Life Sciences, Cell Biology, Hematology +16

Novel sulfonamides as potential, systemically active antitumor agents

Hiroshi Yoshino, Norihiro Ueda, Jun Niijima et al. · Journal of Medicinal Chemistry · 1992 · 233 citations

Medicine, Medicinal Chemistry, Pharmacology +5

Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.

Kumiko Yoshimatsu, Atsumi Yamaguchi, Hiroshi Yoshino et al. · PubMed · 1997 · 181 citations

Medicine, Oncology, Pharmacology +14

E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo

Yoichi Ozawa, Naoko Hata Sugi, Takeshi Nagasu et al. · European Journal of Cancer · 2001 · 134 citations

Pharmacy, Medicinal Chemistry, Pharmacology +4

1–5 of 34